Adverse events following immunization
Assessment of knowledge of multipurpose health workers regarding adverse events following immunization in a rural block of Haryana, India
5
Factors associated with adverse events following immunization in Albanian children: An analysis of the national database of adverse events after immunization
7
Surveillance for Adverse Events following Immunization from 2008 to 2011 in Zhejiang Province, China
7
Risk of Recurrence of Adverse Events Following Immunization: A Systematic Review
17
Adverse Effects of Inactivated Foot and Mouth Disease Vaccine—Possible Causes Analysis and Countermeasures
8
Knowledge, perceptions and practice of nurses on surveillance of adverse events following childhood immunization in Nairobi county, Kenya
82
Primary immunodeficiency disease: a retrospective study of 112 Chinese children in a single tertiary care center
7
Necrotizing fasciitis following measles vaccine administration: a case report
5
TREND ANALYSIS OF THE CASES OF ADVERSE EVENT FOLLOWING IMMUNIZATION (AEFI) REPORTED IN NIGERIA BETWEEN 2011 AND 2018
11
Adverse Event Following Immunization and its Management in Pediatric Population
67
PubMedCentral-PMC5139811.pdf
9
Early molecular correlates of adverse events following yellow fever vaccination
13
Neurological Disorders Associated with Measles-Mumps-Rubella Vaccination- a Review
6
Solicited Adverse Events After Influenza Immunization Among Infants, Toddlers, and Their Household Contacts
11
Understanding the Role of Human Variation in Vaccine Adverse Events: The Clinical Immunization Safety Assessment Network
11
Active safety monitoring of measles-mumps-rubella vaccine in the National Immunisation Programme of Sri Lanka
8
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)
8
Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data.
12
Platelet rich plasma in Achilles tendon healing 2 (PATH 2) trial: statistical analysis plan for a multicentre, double blinded, parallel group, placebo controlled randomised clinical trial
10
Preventing drug-related adverse events following hospital discharge: the role of the pharmacist
9